McKesson Corporation (MCK)

Over the past six months, McKesson's stock price has experienced significant movements, including a surge to a 52-week high followed by declines due to analyst price target adjustments and concerns over GLP-1 drug pricing. Insider selling activity and institutional portfolio adjustments also contributed to market sentiment. Despite these pressures, strong third-quarter results and raised full-year guidance provided support for the stock. A planned CFO transition was announced with Britt Vitalone retiring and Kenny Cheung named as the incoming CFO.

McKesson leverages advanced analytics and machine learning to detect patient dispense demand patterns, seasonality, and volatility in its supply chain. A milder-than-usual flu and respiratory season in fiscal third quarter of 2026 led to reduced demand for vaccines, testing supplies, and physician office products within the Medical-Surgical Solutions segment.

McKesson Corporation is a leading American healthcare services and distribution company operating in pharmaceutical distribution and healthcare information technology. Its business is divided into four segments: North American Pharmaceutical, Oncology and Multispecialty, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The company provides wholesale drug distribution, integrated solutions for oncology and multispecialty practices, medical-surgical supplies distribution, and medication access solutions.

McKesson Corporation is headquartered in Irving, Texas, with a global presence including corporate offices and distribution centers. The majority of its revenue comes from the United States, while its international segment serves customers in Canada and 13 European countries.

In the past year, McKesson has focused on its purpose of "Advancing Health Outcomes for All®" and has been recognized for its commitment to being an impact-driven organization. The company has achieved milestones in improving healthcare access and equity, embracing technology and innovation, and accelerating sustainability priorities. McKesson has received external recognition as one of America's Greatest Workplaces for Diversity and as a Military Friendly Employer. While there's a historical mention of a federal lawsuit regarding the opioid epidemic, recent news primarily highlights positive contributions and corporate responsibility efforts.

McKesson Corporation's ownership is heavily dominated by institutional investors, holding approximately 78% to 89% of the shares. The largest institutional shareholders include The Vanguard Group, Inc., BlackRock, Inc., and State Street Corp. The general public, including retail investors, owns approximately 10% to 22% of the company.